Patents by Inventor Menno Van Lookeren

Menno Van Lookeren has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Anti-factor D antibodies
    Patent number: 10179821
    Abstract: The invention relates to anti-Factor D antibody variants, their production and their use in the preparation of compositions and medicaments for treatment of diseases and disorders associated with excessive or uncontrolled complement activation.
    Type: Grant
    Filed: April 30, 2015
    Date of Patent: January 15, 2019
    Assignee: GENENTECH, INC.
    Inventors: Robert F Kelley, Menno van Lookeren Campagne, Justin M Scheer, Philip E Hass, Devin Tesar
  • NSP4 INHIBITORS AND METHODS OF USE
    Publication number: 20180371107
    Abstract: The invention provides NSP4 inhibitors (such as anti-NSP4 antibodies) and methods of using the same.
    Type: Application
    Filed: April 20, 2018
    Publication date: December 27, 2018
    Applicant: Genentech, Inc.
    Inventors: Shuo-Yen Jack LIN, Daniel K. KIRCHHOFER, Menno VAN LOOKEREN CAMPAGNE
  • Anti-interleukin-33 antibodies and uses thereof
    Patent number: 10093730
    Abstract: The invention provides interleukin-33 (IL-33) antibodies and methods of using the same.
    Type: Grant
    Filed: November 10, 2015
    Date of Patent: October 9, 2018
    Assignee: Genentech, Inc.
    Inventors: Philip E. Hass, Meredith Hazen, Yi-Chun Hsiao, Rajita Khosla, Gerald R. Nakamura, Dhaya Seshasayee, Menno Van Lookeren Campagne, Hongkang Xi, Wenwu Zhai, Jack Bevers, III, Nancy Chiang
  • NSP4 inhibitors and methods of use
    Patent number: 9975963
    Abstract: The invention provides NSP4 inhibitors (such as anti-NSP4 antibodies) and methods of using the same.
    Type: Grant
    Filed: April 8, 2016
    Date of Patent: May 22, 2018
    Assignee: Genentech, Inc.
    Inventors: Shuo-Yen Jack Lin, Daniel K. Kirchhofer, Menno Van Lookeren Campagne
  • HUMANIZED ANTI-FACTOR D ANTIBODIES AND USES THEREOF
    Publication number: 20180100024
    Abstract: The invention relates to anti-Factor D antibodies, their nucleic acid and amino acid sequences, the cells and vectors that harbor these antibodies and their production and their use in the preparation of compositions and medicaments for treatment of diseases and disorders associated with excessive or uncontrolled complement activation. These antibodies are useful for diagnostics, prophylaxis and treatment of disease.
    Type: Application
    Filed: May 18, 2017
    Publication date: April 12, 2018
    Inventors: Arthur HUANG, Robert KELLEY, Henry LOWMAN, Menno VAN LOOKEREN CAMPAGNE, Charles WINTER
  • PREVENTION AND TREATMENT OF COMPLEMENT-ASSOCIATED EYE CONDITIONS
    Publication number: 20180079826
    Abstract: The invention concerns the prevention and treatment of complement-associated eye conditions, such as choroidal neovascularization (CNV) and age-related macular degeneration (AMD), by administration of Factor D antagonists.
    Type: Application
    Filed: November 29, 2017
    Publication date: March 22, 2018
    Applicant: Genentech, Inc.
    Inventors: Philip Hass, Yin Jianping, Kenneth Katschke, Micah Steffek, Christian Weismann, Menno Van Lookeren Campagne
  • ANTI-FACTOR B ANTIBODIES AND THEIR USES
    Publication number: 20180037667
    Abstract: The invention concerns the prevention and treatment of complement-associated eye conditions, such as choroidal neovascularization (CNV) and age-related macular degeneration (AMD), by administration of factor B antagonists.
    Type: Application
    Filed: October 23, 2017
    Publication date: February 8, 2018
    Inventors: Menno Van Lookeren Campagne, Laura Deforge
  • ANTI-HtrA1 ANTIBODIES AND METHODS OF USE
    Publication number: 20170342163
    Abstract: The invention provides anti-HtrA1 antibodies and methods of using the same.
    Type: Application
    Filed: July 18, 2017
    Publication date: November 30, 2017
    Inventors: Yan WU, Menno van LOOKEREN CAMPAGNE, Daniel KIRCHHOFER, Michael Terry LIPARI, Kenneth J. KATSCHKE, Jr., Paul M. MORAN, Scott STAWICKI, Wei-Ching LIANG
  • Anti-HtrA1 antibodies and methods of use
    Patent number: 9738727
    Abstract: The invention provides anti-HtrA1 antibodies and methods of using the same.
    Type: Grant
    Filed: October 12, 2012
    Date of Patent: August 22, 2017
    Assignee: Genentech, Inc.
    Inventors: Yan Wu, Menno van Lookeren-Campagne, Daniel Kirchhofer, Michael Terry Lipari, Kenneth J. Katschke, Jr., Paul M. Moran, Scott Stawicki, Wei-Ching Liang
  • Humanized anti-factor D antibodies and uses thereof
    Patent number: 9676868
    Abstract: The invention relates to anti-Factor D antibodies, their nucleic acid and amino acid sequences, the cells and vectors that harbor these antibodies and their production and their use in the preparation of compositions and medicaments for treatment of diseases and disorders associated with excessive or uncontrolled complement activation. These antibodies are useful for diagnostics, prophylaxis and treatment of disease.
    Type: Grant
    Filed: September 20, 2013
    Date of Patent: June 13, 2017
    Assignee: GENENTECH, INC.
    Inventors: Arthur Huang, Robert Kelley, Henry Lowman, Menno Van Lookeren Campagne, Charles Winter
  • ANTI-FACTOR D ANTIBODY VARIANT CONJUGATES AND USES THEREOF
    Publication number: 20170143843
    Abstract: The disclosure relates to antibody-polymer conjugates comprising one or more anti-Factor D antibody variants, their production and their use in the preparation of compositions and medicaments for treatment of diseases and disorders associated with excessive or uncontrolled complement activation.
    Type: Application
    Filed: October 27, 2016
    Publication date: May 25, 2017
    Inventors: Philip E. Hass, Robert F. Kelley, Justin M. Scheer, Whitney Shatz, Devin Tesar, Menno van Lookeren Campagne
  • ANTI-HtrA1 ANTIBODIES AND METHODS OF USE THEREOF
    Publication number: 20170145113
    Abstract: The present invention provides anti-HtrA1 antibodies (including bispecific anti-HtrA1 anti-Factor D antibodies) and methods of making and using the same, for example, in methods of treating HtrA1-associated disorders, ocular disorders, and/or complement-associated disorders.
    Type: Application
    Filed: October 27, 2016
    Publication date: May 25, 2017
    Inventors: Robert F. KELLEY, Daniel K. KIRCHHOFER, Joyce LAI, Chingwei V. LEE, Wei-Ching LIANG, Michael T. LIPARI, Kelly M. LOYET, Tao SAI, Menno VAN LOOKEREN CAMPAGNE, Yan WU, Germaine FUH
  • TREATMENT OF COMPLEMENT-ASSOCIATED DISORDERS
    Publication number: 20170042967
    Abstract: The present invention concerns a recently discovered macrophage specific receptor, CRIg, and its use in the treatment of complement-associated disorders.
    Type: Application
    Filed: March 9, 2016
    Publication date: February 16, 2017
    Inventors: Avi Ashkenazi, Karim Yussef Helmy, Sherman Fong, Audrey Goddard, Austin L. Gurney, Kenneth James Katschke, Jr., Menno Van Lookeren, William I. Wood
  • PREVENTION AND TREATMENT OF COMPLEMENT-ASSOCIATED EYE CONDITIONS
    Publication number: 20160272726
    Abstract: The invention concerns the prevention and treatment of complement-associated eye conditions, such as choroidal neovascularization (CNV) and age-related macular degeneration (AMD), by administration of Factor D antagonists.
    Type: Application
    Filed: February 3, 2016
    Publication date: September 22, 2016
    Inventors: Philip HASS, Yin Jianping, Kenneth Katschke, JR., Micah Steffek, Christian Weismann, Menno Van Lookeren Campagne
  • NSP4 INHIBITORS AND METHODS OF USE
    Publication number: 20160215065
    Abstract: The invention provides NSP4 inhibitors (such as anti-NSP4 antibodies) and methods of using the same.
    Type: Application
    Filed: April 8, 2016
    Publication date: July 28, 2016
    Applicant: Genentech, Inc.
    Inventors: Shuo-Yen Jack LIN, Daniel K. KIRCHHOFER, Menno VAN LOOKEREN CAMPAGNE
  • ANTI-INTERLEUKIN-33 ANTIBODIES AND USES THEREOF
    Publication number: 20160168242
    Abstract: The invention provides interleukin-33 (IL-33) antibodies and methods of using the same.
    Type: Application
    Filed: November 10, 2015
    Publication date: June 16, 2016
    Inventors: Philip E. HASS, Meredith HAZEN, Yi-Chun HSIAO, Rajita KHOSLA, Gerald R. NAKAMURA, Dhaya SESHASAYEE, Menno VAN LOOKEREN CAMPAGNE, Hongkang XI, Wenwu ZHAI, Jack BEVERS, III, Nancy CHIANG
  • Humanized Anti-Factor D Antibodies And Uses Thereof
    Publication number: 20160145349
    Abstract: The invention relates to anti-Factor D antibodies, their nucleic acid and amino acid sequences, the cells and vectors that harbor these antibodies and their production and their use in the preparation of compositions and medicaments for treatment of diseases and disorders associated with excessive or uncontrolled complement activation. These antibodies are useful for diagnostics, prophylaxis and treatment of disease.
    Type: Application
    Filed: November 23, 2015
    Publication date: May 26, 2016
    Inventors: Arthur Huang, Robert Kelley, Henry Lowman, Menno Van Lookeren Campagne, Charles Winter
  • ANTI-FACTOR B ANTIBODIES AND THEIR USES
    Publication number: 20160024224
    Abstract: The invention concerns the prevention and treatment of complement-associated eye conditions, such as choroidal neovascularization (CNV) and age-related macular degeneration (AMD), by administration of factor B antagonists.
    Type: Application
    Filed: October 6, 2015
    Publication date: January 28, 2016
    Inventors: Menno Van Lookeren Campagne, Laura Deforge
  • Anti-Factor D Antibody Variants and Uses Thereof
    Publication number: 20160017052
    Abstract: The invention relates to anti-Factor D antibody variants, their production and their use in the preparation of compositions and medicaments for treatment of diseases and disorders associated with excessive or uncontrolled complement activation.
    Type: Application
    Filed: April 30, 2015
    Publication date: January 21, 2016
    Applicant: GENENTECH, INC.
    Inventors: Robert F. Kelley, Menno van Lookeren Campagne, Justin M. Scheer, Philip E. Hass, Devin Tesar
  • AFFINITY MATURED CRIg VARIANTS
    Publication number: 20160008427
    Abstract: The present invention concerns affinity matured CRIg variants. In particular, the invention concerns CRIg variants having increased binding affinity to C3b and retaining selective binding to C3b over C3.
    Type: Application
    Filed: April 20, 2015
    Publication date: January 14, 2016
    Applicant: GENENTECH, INC.
    Inventors: Sachdev S. SIDHU, Bing LI, Menno VAN LOOKEREN CAMPAGNE, Christian WIESMANN